ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Communication"

  • Abstract Number: 1861 • 2019 ACR/ARP Annual Meeting

    Use of a Novel Electronic Auto-notification Process to Manage Transitions of Care in Rheumatic Patients on DMARD Therapy

    Megan Bielawski1, Eric Newman 2 and Lisa Schroeder 1, 1Geisinger Medical Center, Danville, PA, 2Geisinger, Danville, PA

    Background/Purpose: Effective communication is essential in caring for medically complex patients with rheumatologic diseases. In our prior study of rheumatoid arthritis patients and hospital admissions,…
  • Abstract Number: 2271 • 2019 ACR/ARP Annual Meeting

    Sexual Health, Intimacy and Rheumatology Practices

    Julie Schwartzman-Morris1, Arianna Leo 2 and Preeya Nandkumar 2, 1Division of Rheumatology, Northwell Health, Great Neck, NY, 2Division of Rheumatology, Northwell Health, Great Neck

    Background/Purpose: Patients with chronic illness often face challenges with their sexual health and intimacy. The issues can be inherent to the disease state, self-image, or…
  • Abstract Number: 2342 • 2018 ACR/ARHP Annual Meeting

    A Pan-Canadian Study of Factors Associated with Perceived Doctor-Patient Communication in Patients with Systemic Lupus Erythematosus

    Deborah Da Costa1, Carolyn Neville2, Anne-Sophie Julien3, Murray Rochon4, Davy Eng5, Christine A. Peschken6, Evelyne Vinet7, C Douglas Smith8, Mark Matsos9, Janet E. Pope10, Ann E. Clarke11, Stephanie Keeling12, J. Antonio Avina-Zubieta13, Marie Hudson14 and Paul R. Fortin15, 1Medicine, McGill University, Montreal, QC, Canada, 2Department of Medicine, McGill University Health Center, Montreal, QC, Canada, 3CHU de Québec - Université Laval, Quebec City, QC, Canada, 4Jack Digital, Toronto, ON, Canada, 5Centre de recherche du CHU de Québec, Université Laval, Québec, QC, Canada, 6RR 149G, University of Manitoba, Winnipeg, MB, Canada, 7Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, 8The Arthritis Centre, TOH Riverside Campus, Ottawa, ON, Canada, 9Medicine, McMaster University, Hamilton, ON, Canada, 10Department of Medicine, University of Western Ontario, London, ON, Canada, 11Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 12Department of Medicine, University of Alberta, University of Alberta, Edmonton, AB, Canada, 13Division of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada, 14Division of Rheumatology, Jewish General Hospital, Lady Davis Institute for Medical Research, Montreal, QC, Canada, 15Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with fluctuating levels of disease activity, which may require frequent encounters with the medical system…
  • Abstract Number: 2375 • 2018 ACR/ARHP Annual Meeting

    When Are People Receptive to Self Management Education Information, and What Information Appeals to Them? : An Analysis of Digital Data

    Teresa Brady1, Meghan Lewis2 and Carla Cartwright2, 1Clarity Consulting and Communications, Atlanta, GA, 2Porter Novelli, Atlanta, GA

    Background/Purpose:   CDC pilot-tested a marketing campaign to promote self-management education (SME) as a chronic disease management strategy.  The campaign targets adults ages 45-75 with…
  • Abstract Number: 2941 • 2018 ACR/ARHP Annual Meeting

    Reach and Effectiveness of a Health Communications Campaign Promoting Self Management Education: Results of a Pilot Test of the Learn More. Feel Better. Campaign

    Teresa Brady1, Meghan Lewis2, Carla Cartwright2, Anne Hvizdak3 and Sara Lasker4, 1Clarity Consulting and Communications, Atlanta, GA, 2Porter Novelli, Atlanta, GA, 3Bureau of Aging and Disability Resources, Wisconsin Department of Health Services, Madison, WI, 4Healthy & Hygge, Madison, WI

    Background/Purpose: Learn More. Feel Better. (LMFB) is a multi-modal marketing campaign to promote self-management education (SME) as a chronic disease management strategy. The campaign targets…
  • Abstract Number: PP07 • 2018 ACR/ARHP Annual Meeting

    Strengthening My Resiliency: How My Interprofessional Healthcare Team and I Improved My Management of Lupus

    Cecilia Amoakohene1, Jorge Sanchez-Guerrero2, Murray Urowitz2, Dafna D Gladman2, Zahi Touma2 and Laura Wakani2, 1Unaffiliated, Toronto, ON, Canada, 2University of Toronto Lupus Research Program, Toronto Western Hospital, Toronto, ON, Canada

    Background/Diagnosis: I was diagnosed with systemic lupus erythematosus (SLE) at the age of eleven and have experienced multiple SLE flares, hospitalizations, invasive procedures and complex…
  • Abstract Number: PP08 • 2018 ACR/ARHP Annual Meeting

    Communication, Support, and Advocacy Lead to Improved Health and Quality of Life

    Christele Felix, AztraZeneca, Gaithersburg, MD

    Background/Diagnosis: In 2007 I was diagnosed with Lupus which has since then wreaked havoc on my kidneys, lungs, GI tract, peripheral nervous system, to name…
  • Abstract Number: 280 • 2018 ACR/ARHP Annual Meeting

    Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus

    R. Paola Daly1, Nicole Wanty2, Maggie Maloney1, Stacey Boyd3, Karin Tse1 and Karen Goldstein4, 1Lupus Foundation of America, Washington, DC, 2KDH Research & Communication, Atlanta, GA, 3American College of Rheumatology, Atlanta, GA, 4Ogilvy, Washington, DC

    Background/Purpose: Lupus is a complex, chronic autoimmune disease that has significantly higher prevalence and incidence among minority women.[i] In an effort to reduce the time…
  • Abstract Number: 1390 • 2018 ACR/ARHP Annual Meeting

    Impact of Psoriatic Arthritis from the Patient’s Perspective in the Context of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire: An Online Global Survey

    Laura C. Coates1, Ana-Maria Orbai2, Valderilio F Azevedo3, Joseph C Cappelleri4, Jade Moser5, Ralph Lippe6, Irwin Lim7, Lihi Eder8, Pascal Richette9, Meng-Yu Weng10, Rubén Queiro11 and Lara Fallon12, 1University of Oxford, Oxford, United Kingdom, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Universidade Federal do Paraná, Curitiba, Brazil, 4Pfizer Inc, Groton, CT, 5The Harris Poll, Rochester, NY, 6Pfizer Pharma GmbH, Berlin, Germany, 7BJC Health, Sydney, Australia, 8Women’s College Research Institute, University of Toronto, Toronto, ON, Canada, 9Lariboisière Hospital, Lariboisière, University of Paris 7, Paris, France, 10Department of Internal Medicine, Division of Allergy, Immunology and Rheumatology, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan, 11Rheumatology Division, HUCA, Oviedo, Spain, 12Pfizer Canada, Montreal, QC, Canada

    Background/Purpose: Psoriatic arthritis (PsA) is a complex disease with high impact on quality of life (QoL). The PsA core domain set1 includes pain, patient (pt)…
  • Abstract Number: 1925 • 2018 ACR/ARHP Annual Meeting

    Goal Concordance in Rheumatoid Arthritis: Beyond Pain Reduction, Is There Agreement?

    Jennifer Barton1,2, Shelia Markwardt2, Allison Schue1, Somnath Saha2,3 and Edward H. Yelin4, 1VA Portland Health Care System, Portland, OR, 2Oregon Health & Science University, Portland, OR, 3Medicine, VA Portland Health Care System, Portland, OR, 4Medicine/Rheumatology, University of California San Francisco, San Francisco, CA

    Background/Purpose: Goal concordance between patients with chronic diseases and their clinicians has been linked to improved outcomes, but not explored in rheumatoid arthritis (RA). Our…
  • Abstract Number: 1928 • 2018 ACR/ARHP Annual Meeting

    Patient-Physician Communication about Medication Costs in Rheumatoid Arthritis

    K. Julia Kaal1, Nick Bansback1,2,3, Aslam Anis4,5 and Mark Harrison5,6,7,8, 1University of British Columbia, Vancouver, BC, Canada, 2St Paul's Hospital, Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, 3Arthritis Research Canada, Richmond, BC, Canada, 4University of British Columbia, School of Population and Public Health, Vancouver, BC, Canada, 5Centre for Health Evaluation and Outcomes Sciences, Vancouver, BC, Canada, 6Arthritis Research Canada, Vancouver, BC, Canada, 7Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 8Collaborations in Outcomes Research and Evaluation, Vancouver, BC, Canada

    Background/Purpose: Patients often have to pay for prescription medications out-of-pocket and cost-related nonadherence is a recognized problem. The treatment of rheumatoid arthritis is associated with…
  • Abstract Number: 2187 • 2018 ACR/ARHP Annual Meeting

    Specialist Link Telephone Advice Cost Effectively Enhances Rheumatology Patient Care in Alberta, Canada

    Yolanda Martens-Vanhilst1, Dianne P. Mosher2, Linda Slocombe1 and Paul MacMullan3, 1University of Calgary, Calgary, AB, Canada, 2Med, University of Calgary, Calgary, AB, Canada, 3Medicine, Division of Rheumatology, University of Calgary, Calgary, AB, Canada

    Background/Purpose: The Calgary zone of Alberta Health Services serves a population of almost 2million Canadians over a wide geographical area and is underserved in terms…
  • Abstract Number: 2341 • 2018 ACR/ARHP Annual Meeting

    A Link between Quality of Patient–Rheumatologist Communication and Patient Healthcare Needs in Psoriatic Arthritis: An Online Survey of US-Based Patients and Rheumatologists

    Ana-Maria Orbai1, Laura C. Coates2, Valderilio F Azevedo3, Amit Garg4, Amar Majjhoo5, Christopher E M Griffiths6, Pamela Young7, Joseph C Cappelleri8, Jade Moser9 and Lara Fallon10, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2University of Oxford, Oxford, United Kingdom, 3Universidade Federal do Paraná, Curitiba, Brazil, 4Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, 5Shores Rheumatology, St Clair Shores, MI, 6Dermatology Centre, University of Manchester, Manchester, United Kingdom, 7Pfizer Inc, Collegeville, PA, 8Pfizer Inc, Groton, CT, 9The Harris Poll, Rochester, NY, 10Pfizer Canada, Montreal, QC, Canada

    Background/Purpose: Patient (pt)–rheumatologist (rheum) communication may influence symptom reporting and disease control in psoriatic arthritis (PsA). This online survey evaluated pt–rheum communication and assessed PsA…
  • Abstract Number: 358 • 2017 ACR/ARHP Annual Meeting

    Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis

    M. Elaine Husni1,2, Anthony Fernandez1, Rakesh Singh3, Brett Hauber4, Jessie Sutphin4, Joshua Posner4 and Arijit Ganguli3, 1Cleveland Clinic, Cleveland, OH, 2Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH, 3AbbVie Inc., North Chicago, IL, 4RTI Health Solutions, Research Triangle Park, NC

    Background/Purpose: Psoriasis and psoriatic arthritis arise from the same immune system response but result in different symptoms and impacts on daily activities. A patient with…
  • Abstract Number: 1100 • 2017 ACR/ARHP Annual Meeting

    Communication between Inpatient and Outpatient Specialty Clinicians: Developing a Better Understanding of Patients with Rheumatoid Arthritis Who Are Admitted to the Hospital

    Abraham Tacang1, Christina Downey2, Alfred Denio1, Eric Newman3 and Lisa L. Schroeder4, 1Rheumatology, Geisinger Medical Center, Danville, PA, 2Geisinger Medical Center, Danville, PA, 3Department of Rheumatology, Geisinger Medical Center, Danville, PA, 4Rheumatology, Geisinger Health System, Danville, PA

    Background/Purpose: Effective communication is essential in caring for medically complex patients with rheumatoid arthritis (RA). Communication between clinicians becomes even more crucial when a patient…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology